Your browser doesn't support javascript.
loading
Ixazomib-induced cutaneous necrotizing vasculitis.
Alloo, A; Khosravi, H; Granter, S R; Jadeja, S M; Richardson, P G; Castillo, J J; LeBoeuf, N R.
Afiliación
  • Alloo A; Department of Dermatology, Northwell Health, Hofstra Northwell School of Medicine, Hempstead, NY, USA.
  • Khosravi H; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Granter SR; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Jadeja SM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Richardson PG; Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Boston, MA, USA.
  • Castillo JJ; The Center for Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • LeBoeuf NR; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. nleboeuf@partners.org.
Support Care Cancer ; 26(7): 2247-2250, 2018 Jul.
Article en En | MEDLINE | ID: mdl-29392482

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vasculitis / Compuestos de Boro / Inhibidores de Proteasoma / Glicina Tipo de estudio: Prognostic_studies Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vasculitis / Compuestos de Boro / Inhibidores de Proteasoma / Glicina Tipo de estudio: Prognostic_studies Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2018 Tipo del documento: Article